{"text_format":"2","workbook":"xls","n_sheets":1,"sheets":["report2"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":1,"defined_names":2,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"report2","index":0,"n_rows":31,"n_cols":5,"rows_kept":31,"cut":false,"hidden":false,"merged":[[0,2,0,3],[0,4,0,5],[1,2,1,3],[1,4,1,5],[2,2,2,3],[2,4,2,5],[3,2,3,3],[4,2,4,3],[5,2,5,3],[6,2,6,3],[7,2,7,3],[8,2,8,3],[9,2,9,3],[10,2,10,3],[11,2,11,3],[13,2,13,3],[13,4,13,5],[14,2,14,3],[14,4,14,5],[15,2,15,3],[16,2,16,3],[17,2,17,3],[18,2,18,3],[26,2,26,3],[27,2,27,3]],"flags":["formulas_cached_only"]}
[null,"1.","Record Nr.",null,"UNISA990001134680203316"]
[null,null,"Autore",null,"JÜNGEL, Eberhard"]
[null,null,"Titolo",null,"Gott als Geheimnis der Welt : Zur Begründung der Theologie des Gekreuzigten im Streit zwischen Theismus und Atheismus / Eberhard Jüngel"]
[null,null,"Pubbl/distr/stampa",null,"Tübingen : Mohr Siebeck, 2001"]
[null,null,"ISBN",null,"3-16-147620-4"]
[null,null,"Edizione",null,"[7. Auflage um ein Vorwort ergänzt]"]
[null,null,"Descrizione fisica",null,"XXI, 564 p. ; 24 cm."]
[null,null,"Disciplina",null,"231"]
[null,null,"Soggetti",null,"Dio"]
[null,null,"Collocazione",null,"II 2 2341(XIV 1600)"]
[null,null,"Lingua di pubblicazione",null,"Tedesco"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,"2.","Record Nr.",null,"UNINA9910715017103321"]
[null,null,"Titolo",null,"Fairness in Orphan Drug Exclusivity Act : report (to accompany H.R. 4712)"]
[null,null,"Pubbl/distr/stampa",null,"[Washington, D.C.] : , : [U.S. Government Publishing Office], , [2020]"]
[null,null,"Descrizione fisica",null,"1 online resource (11 pages)"]
[null,null,"Collana",null,"Report / 116th Congress, 2d session, House of Representatives ; ; 116-572"]
[null,null,"Soggetti",null,"Drug development - Economic aspects - United States"]
[{"$nulls":4},"Buprenorphine - Therapeutic use - United States"]
[{"$nulls":4},"Orphan drugs - Government policy - United States"]
[{"$nulls":4},"Drugs - Prices - Government policy - United States"]
[{"$nulls":4},"Drugs - Law and legislation - United States"]
[{"$nulls":4},"Orphan drugs - United States"]
[{"$nulls":4},"Rare diseases - United States"]
[{"$nulls":4},"Legislative materials."]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,null,"Note generali","\"November 16, 2020.\""]
[null,null,null,"Nota di bibliografia","Includes bibliographical references."]